How many patents does
Acucela have?
patents
332
families
27
granted
69
applications
263
US
76
EP
28
CN
21
WO
17
JP
17
KR
9
GB
7
RoW
157
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Acucela
Top ten assignees appearing on patents
2009 - 2018
| acucela | 270 |
| revision therapeutics | 12 |
| little, thomas | 10 |
| sirion therapeutics | 9 |
| sirion terapeutics | 1 |
| acuacela | 1 |
2009
| acucela | 25 |
| sirion therapeutics | 3 |
| sirion terapeutics | 1 |
2018
| acucela | 7 |
Acucela
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| alkoxy compounds for disease treatment | 53 | 2007 |
| amine derivative compounds for treating ophthalmic diseases and disorders | 42 | 2007 |
| alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders | 39 | 2007 |
| compounds for treating ophthalmic diseases and disorders | 31 | 2008 |
| styrenyl derivative compounds for treating ophthalmic diseases and disorders | 30 | 2007 |
| sulfur-linked compounds for treating opthalmic diseases and disorders | 26 | 2008 |
| substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and… 🛈 | 24 | 2013 |
| methods for the treatment of diabetic retinopathy and other ophthalmic diseases | 21 | 2012 |
| methods and compositions for treating ophthalmic conditions with retinyl derivatives | 17 | 2004 |
| substituted heterocyclic compounds for disease treatment | 9 | 2012 |